Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
bullish
Veeva Systems Inc Class A
Watchlist
자동화와 유연성의 만남: Veeva Systems가 AI와 CRM 통합으로 제약 기술에 혁신을 가져오는 방법!
Equity Bottom-Up
528 Views
19 Mar 2025 09:00
This page has been machine-translated. Click
here
to revert to original page
생명 과학 클라우드 소프트웨어 업계의 유명 기업인 Veeva Systems는 최근 2025 회계연도 4분기와 연간 실적을 보고했습니다.
전체 통찰력에서 다루는 내용:
Veeva Systems 소개
재무 실적 개요
전략적 확장 및 AI 전략
클라이언트 채택 및 시장 동향
평가 방법론 및 시나리오
요약
(접속하기 위해 가입하세요)
전체 통찰력
(유료 플랜만, 48-분 읽기)
관련 통찰력
More »
Veeva Systems Ignites a Digital Revolution with Crossix—Biopharma’s Secret Weapon!
Automation Meets Flexibility: How Veeva Systems Is Disrupting Pharma Tech With AI & CRM Integration!
Veeva Systems’ Vault CRM Revolution: How Smart Migrations Are Fueling Industry Domination! - Major Drivers
Veeva Systems: Continued Expansion and Adoption of Vault Platform As A Key Growth Lever! - Major Drivers
Veeva Systems: Can The Growth Potential Offered By Vault CRM Catalyze Growth? - Major Drivers
인기 컬렉션
More »
Index Rebalance
Japan
Event-Driven
Equity Bottom-Up
South Korea
Sell / Short Ideas
Singapore
Philippines
India
Semiconductors
트렌드 통찰력
More »
MV Australia Equal Weight Index Rebalance Preview: Three Potential Deletions in September
Lynch Group (LGL AU): (Another) Clean Offer From TPG
Pop Mart (9992 HK): Revenue Up by 204%, Margin Up by 17 PPT, 64% Upside
HMM Tender Side Play: Targeting a Basis Squeeze Ahead of Sep Expiry
Hang Seng Index (HSI) Outlook Ahead of Sep25 Rebalance
최고의 유료화되지 않은 통찰력
More »
Kyivstar (KYIV US): Structural Long – From Ukraine’s Resilience to Renewal; Uklon Embedded Value
How to Own Lenovo at a Discount: BUY Legend Holdings Corp (3396 HK)
Institutions Are Coming for Bitcoin — UTXO’s Loren Asmus Explains How
Curator's Cut: Singapore Unlocks Value, India’s Jewellery Caution & Taiwan's Top ETF's Rebalance
[IO Technicals 2025/33] China Woes Deepen, Bearish Momentum Grips Iron Ore
토론
(유료 플랜만)
가격 차트
(접속하기 위해 가입하세요)
인사이트 스트림
Automation Meets Flexibility: How Veeva Systems Is Disrupting Pharma Tech With AI & CRM Integration!
19 Mar 2025
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.3
x